FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4386813239> ?p ?o ?g. }

• W4386813239 endingPage "100676" @default.
• W4386813239 startingPage "100676" @default.
• W4386813239 abstract "To report on the late toxicity and local control (LC) of head and neck cancer patients treated with adaptive FDG-PET/CT response-guided radiotherapy (ADMIRE) with dose escalation (NCT03376386).Between December 2017 and April 2019, 20 patients with stage II-IV squamous cell carcinoma of the larynx, hypopharynx or oropharynx were treated within the ADMIRE study where FDG-PET/CT response-guided (Week 2&4) dose escalation was applied (total dose 70-78 Gy). Cisplatin or cetuximab was added to radiotherapy in case of T3-4 and/or N2c disease. To compare the LC and late toxicity of the study population, we used an external control group (n = 67) consisting of all eligible patients for the study (but not participated). These patients were treated in our institution during the same period with the current standard of 70 Gy radiotherapy. To reduce the effect of confounding, logistic regression analyses was done using stabilized inverse probability of treatment weighting (SIPTW).After median follow-up of 40 and 43 months for the ADMIRE and control groups, the 3-year LC-rates were 74% and 78%, respectively (adjusted HR after SIPTW 0.80, 95 %CI 0.25-2.52, p = 0.70). The incidences of any late G3 toxicity were 35% and 18%, respectively. The adjusted OR for any late G3 toxicity was 5.09 (95 %CI 1.64-15.8, p = 0.005), for any late G ≥ 2 toxicity was 3.67 (95 %CI 1.2-11.7, p = 0.02), for persistent laryngeal edema was 10.95 (95% CI 2.71-44.29, p = 0.001), for persistent mucosal ulcers was 4.67 (95% CI 1.23-17.7, p = 0.023), and for late G3 radionecrosis was 15.69 (95 %CI 2.43-101.39, p = 0.004).Given the comparable LC rates with increased late toxicity in the ADMIRE group, selection criteria for future adaptive dose escalation trials (preferably randomized) need to be refined to include only patients at higher risk of local failure and/or lower risk of severe late toxicity." @default.
• W4386813239 created "2023-09-18" @default.
• W4386813239 creator A5022644824 @default.
• W4386813239 creator A5024540647 @default.
• W4386813239 creator A5026694380 @default.
• W4386813239 creator A5048369598 @default.
• W4386813239 creator A5056758157 @default.
• W4386813239 creator A5062791488 @default.
• W4386813239 creator A5080758695 @default.
• W4386813239 creator A5087851185 @default.
• W4386813239 date "2023-11-01" @default.
• W4386813239 modified "2023-10-03" @default.
• W4386813239 title "Adaptive FDG-PET/CT guided dose escalation in head and neck squamous cell carcinoma: Late toxicity and oncologic outcomes (The ADMIRE study)" @default.
• W4386813239 cites W1968970734 @default.
• W4386813239 cites W1986093144 @default.
• W4386813239 cites W1989207107 @default.
• W4386813239 cites W2054980631 @default.
• W4386813239 cites W2066210329 @default.
• W4386813239 cites W2076797886 @default.
• W4386813239 cites W2086330889 @default.
• W4386813239 cites W2089257078 @default.
• W4386813239 cites W2104783586 @default.
• W4386813239 cites W2136716437 @default.
• W4386813239 cites W2151730005 @default.
• W4386813239 cites W2299116547 @default.
• W4386813239 cites W2740402187 @default.
• W4386813239 cites W2747291617 @default.
• W4386813239 cites W2747656464 @default.
• W4386813239 cites W2889843738 @default.
• W4386813239 cites W3021413207 @default.
• W4386813239 cites W3119504480 @default.
• W4386813239 cites W4200153343 @default.
• W4386813239 cites W4223485945 @default.
• W4386813239 cites W4324333886 @default.
• W4386813239 doi "https://doi.org/10.1016/j.ctro.2023.100676" @default.
• W4386813239 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37753461" @default.
• W4386813239 hasPublicationYear "2023" @default.
• W4386813239 type Work @default.
• W4386813239 citedByCount "0" @default.
• W4386813239 crossrefType "journal-article" @default.
• W4386813239 hasAuthorship W4386813239A5022644824 @default.
• W4386813239 hasAuthorship W4386813239A5024540647 @default.
• W4386813239 hasAuthorship W4386813239A5026694380 @default.
• W4386813239 hasAuthorship W4386813239A5048369598 @default.
• W4386813239 hasAuthorship W4386813239A5056758157 @default.
• W4386813239 hasAuthorship W4386813239A5062791488 @default.
• W4386813239 hasAuthorship W4386813239A5080758695 @default.
• W4386813239 hasAuthorship W4386813239A5087851185 @default.
• W4386813239 hasBestOaLocation W43868132391 @default.
• W4386813239 hasConcept C121608353 @default.
• W4386813239 hasConcept C126322002 @default.
• W4386813239 hasConcept C126838900 @default.
• W4386813239 hasConcept C141071460 @default.
• W4386813239 hasConcept C143998085 @default.
• W4386813239 hasConcept C2776530083 @default.
• W4386813239 hasConcept C2776833033 @default.
• W4386813239 hasConcept C2778496288 @default.
• W4386813239 hasConcept C2779998722 @default.
• W4386813239 hasConcept C2780474809 @default.
• W4386813239 hasConcept C2908647359 @default.
• W4386813239 hasConcept C29730261 @default.
• W4386813239 hasConcept C2989005 @default.
• W4386813239 hasConcept C509974204 @default.
• W4386813239 hasConcept C526805850 @default.
• W4386813239 hasConcept C71924100 @default.
• W4386813239 hasConcept C99454951 @default.
• W4386813239 hasConceptScore W4386813239C121608353 @default.
• W4386813239 hasConceptScore W4386813239C126322002 @default.
• W4386813239 hasConceptScore W4386813239C126838900 @default.
• W4386813239 hasConceptScore W4386813239C141071460 @default.
• W4386813239 hasConceptScore W4386813239C143998085 @default.
• W4386813239 hasConceptScore W4386813239C2776530083 @default.
• W4386813239 hasConceptScore W4386813239C2776833033 @default.
• W4386813239 hasConceptScore W4386813239C2778496288 @default.
• W4386813239 hasConceptScore W4386813239C2779998722 @default.
• W4386813239 hasConceptScore W4386813239C2780474809 @default.
• W4386813239 hasConceptScore W4386813239C2908647359 @default.
• W4386813239 hasConceptScore W4386813239C29730261 @default.
• W4386813239 hasConceptScore W4386813239C2989005 @default.
• W4386813239 hasConceptScore W4386813239C509974204 @default.
• W4386813239 hasConceptScore W4386813239C526805850 @default.
• W4386813239 hasConceptScore W4386813239C71924100 @default.
• W4386813239 hasConceptScore W4386813239C99454951 @default.
• W4386813239 hasLocation W43868132391 @default.
• W4386813239 hasLocation W43868132392 @default.
• W4386813239 hasOpenAccess W4386813239 @default.
• W4386813239 hasPrimaryLocation W43868132391 @default.
• W4386813239 hasRelatedWork W1956415942 @default.
• W4386813239 hasRelatedWork W1977093393 @default.
• W4386813239 hasRelatedWork W1996158748 @default.
• W4386813239 hasRelatedWork W2047962734 @default.
• W4386813239 hasRelatedWork W2070603981 @default.
• W4386813239 hasRelatedWork W2110125130 @default.
• W4386813239 hasRelatedWork W2146329765 @default.
• W4386813239 hasRelatedWork W2405449358 @default.
• W4386813239 hasRelatedWork W3012537123 @default.
• W4386813239 hasRelatedWork W3016922835 @default.
• W4386813239 hasVolume "43" @default.

• next